OncoMatch/Clinical Trials/NCT04770207

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Is NCT04770207 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies Injection of drug-eluting microspheres with multiple drugs into solid tumors for hepatocellular carcinoma.

Phase 2RecruitingSecond Affiliated Hospital of Guangzhou Medical UniversityNCT04770207Data as of May 2026

Treatment: Injection of drug-eluting microspheres with multiple drugs into solid tumors — To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.

Check if I qualify

Extracted eligibility criteria

Cancer type

Hepatocellular Carcinoma

Tumor Agnostic

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify